Search Results

You are looking at 1 - 2 of 2 items for :

Clear All
Open access

Alper Alp, Hakan Akdam, Ibrahim Meteoglu, Emel Ceylan, Arzu Cengiz, Fusun Taskin, Harun Akar and Yavuz Yenicerioglu

the clinical evaluation of sarcoidosis. Semin Roentgenol 1985; 20: 400-409. 12. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluoro- 26, deoxyglucose and carbon-11-methionine evaluation of lympha-denopathy in sarcoidosis. J Nucl Med 1998; 39: 1160-1166. 13. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 27. deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21: 297-305. 14. Krugera S, Buckb AK, Mottaghyb FM, et al. Use of integrated FDG-PET/CT in sarcoidosis. Clinical Imaging 28, 2008; 32

Open access

J. David Spence

ultrasound features of plaque such as echolucency, juxtaluminal black plaque and plaque texture, plaque inflammation on PET/CT, ulceration, reduced cerebral blood flow reserve, intraplaque hemorrhage on MRI, and TCD detection of microemboli. The best validated is TCD embolus detection. Among patients with asymptomatic stenosis, the 10% with two or more microemboli during 1 h of monitoring had a 1-year risk of stroke of 15.6%, compared with a 1% risk among the 90% of patients with no microemboli. The risk with one or more emboli during an hour of monitoring, with repeated